НЕсколько букв по английски
(а потом, что не понятно объясню)

First Therapeutic Brain Cancer Vaccine Approved
12 Jul 2007
Northwest Biotherapeutics has received authorisation for use of its DCVax-Brain vaccine from the Swiss Institute of Public Health, making it the first commercially-available therapeutic vaccine for brain cancer. This authorisation was received substantially ahead of schedule, having only been submitted in Feb 2007.

In clinical trials, DCVax-Brain more than doubled the survival time of both newly-diagnosed and recurrent brain cancer patients, with no sign of any serious side-effects, making it a suitable alternative to chemotherapy. Although the median has not yet been reached, survival in newly-diagnosed patients is currently around 33 months, a vast improvement on a median of only 14.6 months with standard therapy. Expressing confidence in DCVax-Brain and of DCVax's potential for treatment of other cancers, Dr Alton Boynton, President and CEO of Northwest Biotherapeutics said, "We look forward to being able to bring DCVax-Brain to patients in additional countries, and to applying our DCVax technology to many other cancers, including five for which we already have FDA clearance to begin clinical trials".

The vaccine, personalized by combining the patient's dendritic cells with cancer biomarkers derived from the patient's own tumour, is the first of its kind available commercially and is expected to be launched in the third quarter of 2007. EU and US applications are planned for early 2009, following the expected completion of a pivotal US Phase II trial in 141 patients.


(с) http://www.pharmaprojects.com/news/1207_1423.htm

(Reply to this) (Parent)